High CD146 expression also correlated with worse overall survival (OS) in glioma and GBM (Fig. 1F, G), and was associated with worse response to radio- and chemotherapy (Fig. 1H, I, Supplementary Fig. 1A, B). This evidence concerns the gene MCAM and central nervous system cancer.